Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$2.01 - $3.53 $99,450 - $174,657
-49,478 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$1.61 - $2.85 $122,955 - $217,654
-76,370 Reduced 60.68%
49,478 $122,000
Q3 2020

Nov 16, 2020

BUY
$2.04 - $4.03 $256,729 - $507,167
125,848 New
125,848 $257,000
Q3 2019

Nov 14, 2019

SELL
$5.12 - $8.47 $145,505 - $240,708
-28,419 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$5.5 - $7.0 $15,570 - $19,817
-2,831 Reduced 9.06%
28,419 $183,000
Q1 2019

May 14, 2019

SELL
$4.44 - $7.15 $12,844 - $20,684
-2,893 Reduced 8.47%
31,250 $211,000
Q4 2018

Feb 14, 2019

SELL
$4.07 - $10.0 $184,346 - $452,940
-45,294 Reduced 57.02%
34,143 $139,000
Q3 2018

Nov 14, 2018

BUY
$10.0 - $10.88 $794,370 - $864,274
79,437 New
79,437 $864,000

About Entasis Therapeutics Holdings Inc.


  • Ticker ETTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,851,800
  • Market Cap $105M
More about ETTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.